3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 27999210 | LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. | 2017 Feb 7 | 1 |
| 2 | 28806393 | CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles. | 2017 Nov 9 | 1 |
| 3 | 26343583 | Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers. | 2015 Sep 14 | 4 |